内皮的γ-protocadherins抑制KLF2和KLF4,从而促进动脉样硬化
Divyesh Joshi1, Brian G Coon1, Raja Chakraborty1
1Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, School of Medicine, Yale University, New Haven, CT, USA.
Nature cardiovascular research
|September 4, 2024
概括
聚合的玛-protocadherins抑制在动脉样硬化中的保护性KLF2/KLF4基因. 在内皮细胞中准这些抑制剂为动脉样硬化心血管疾病 (ASCVD) 提供了一种新的治疗策略.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 血管炎症 血管炎症
背景情况:
- 动脉样性心血管疾病 (ASCVD) 是一个主要的全球健康问题.
- 内皮KLF2和KLF4转录因子,由层切应力诱导,赋予血管保护ASCVD.
- 识别这些保护性通路的新型调节剂对于治疗开发至关重要.
研究的目的:
- 在ASCVD的背景下,确定调节KLF2和KLF4的新分子标.
- 调查聚合的玛-protocadherins在内皮功能障碍和ASCVD病变的作用.
- 为了评估针对ASCVD治疗的向玛-protocadherins的治疗潜力.
主要方法:
- 作为KLF2和KLF4的调节剂,研究了聚类的玛-原蛋白.
- 进行了涉及蛋白质裂变,核转位和蛋白质-蛋白质相互作用 (玛-原蛋白和Notch细胞内域) 的机制研究.
- 在ASCVD小鼠模型中利用基因删除和抗体阻断,并对人类ASCVD内皮进行分析.
主要成果:
- 集群的玛-protocadherins被确定为强大的抑制KLF2和KLF4,在ASCVD上调.
- 玛-原托卡德林裂变导致其细胞内域的核转移,抑制了Notch信号传递.
- 基因删除或抗体阻断的玛-protocadherins授予保护ASCVD在小鼠,而不会损害免疫防御.
结论:
- 集群的玛-protocadherins通过抑制保护性KLF2/KLF4.4驱动ASCVD血管炎症的关键机制.
- 向玛-原蛋白达林为ASCVD提供了一个有前途的内皮细胞中心治疗策略.
- 这种方法避免了全身免疫抑制,为当前治疗方法提供了更安全的替代方案.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Inflammation
53.2K
Overview
53.2K
Intracellular Signaling Affects Focal Adhesions
2.6K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.6K


